You are here: Industry Insights > Pfizer

News List

When and which COVID-19 vaccines are likely to be available in Asia expresspharma
November 27, 2020
Many Asian countries do not expect to receive big amounts initially, and below are estimated distribution timelines, supply deals announced so far and clinical trials under way in the region.
Pfizer doses first participant in phase 3 study evaluating anti-TFPI investigational therapy pharmaceutical-business-review
November 25, 2020
Pfizer announced that the first participant has been dosed in the Phase 3 BASIS study of marstacimab (PF-06741086), an anti-tissue factor pathway inhibitor (anti-TFPI) being evaluated for the treatment of people with severe hemophilia A or B, with or ...
Sheffield University, Pfizer launch consortium for development of advanced therapy medicinal products expresspharma
November 25, 2020
The University of Sheffield and Pfizer have launched a new consortium which aims to standardise and accelerate the development of Advanced Therapy Medicinal Products (ATMPs), allowing potentially transformative treatments to reach patients sooner.
Pfizer, BioNTech Submit EUA Request for COVID-19 Vaccine americanpharmaceuticalreview
November 24, 2020
Pfizer and BioNTech announced they will submit a request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of their mRNA vaccine candidate, BNT162b2 against SARS-CoV-2, which will potentially enable use of the vaccine ..
Pfizer-BioNTech COVID-19 vaccine may create set of firsts for pharma sector: GlobalData expresspharma
November 23, 2020
In modern history, no vaccine has ever been considered as essential to restoring normality to our way of life as these first mRNA vaccines, says analyst.
Britain may approve COVID-19 vaccine from Pfizer-BioNTech this week, reports Telegraph expresspharma
November 23, 2020
Britain could give regulatory approval to Pfizer-BioNTech’s COVID-19 vaccine this week, even before the US authorises it, the Telegraph news site reported.
Pfizer, BioNTech’s final Covid-19 vaccine study shows 95% efficacy pharmaceutical-technology
November 19, 2020
Pfizer and BioNTech have concluded the Phase III study of their mRNA-based Covid-19 vaccine candidate, BNT162b2, which showed 95% efficacy rate and met all primary efficacy endpoints.
Pfizer files patent infringement petition in US court against Aurobindo, Dr Reddy’s expresspharma
November 19, 2020
Alleges that these Indian pharma companies were planning separately to come out with generic versions of its cancer drug Ibrance (palbociclib) before the expiration of its patent.
Pfizer to commence pilot delivery programme for COVID-19 vaccine in the US expresspharma
November 18, 2020
Pfizer has launched a pilot delivery programme for its experimental COVID-19 vaccine in four US states, as the company seeks to address distribution challenges due to ultra-cold storage requirements.
Moderna, Pfizer raise bar for COVID-19 vaccines, may ward off competing candidates: GlobalData expresspharma
November 17, 2020
While the most effective vaccines will ramp up production to meet global demand, the opportunity for less effective vaccines will wane.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page